BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1851 related articles for article (PubMed ID: 8552387)

  • 21. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
    Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
    Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties.
    Kim J; Lee K; Pelletier J
    Oncogene; 1998 Apr; 16(15):1973-9. PubMed ID: 9591781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.
    Schaefer KL; Wai DH; Poremba C; Korsching E; van Valen F; Ozaki T; Boecker W; Dockhorn-Dworniczak B
    Virchows Arch; 2002 May; 440(5):476-84. PubMed ID: 12021921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
    Crozat A; Aman P; Mandahl N; Ron D
    Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel zinc finger gene is fused to EWS in small round cell tumor.
    Mastrangelo T; Modena P; Tornielli S; Bullrich F; Testi MA; Mezzelani A; Radice P; Azzarelli A; Pilotti S; Croce CM; Pierotti MA; Sozzi G
    Oncogene; 2000 Aug; 19(33):3799-804. PubMed ID: 10949935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy.
    Kaneko Y; Yoshida K; Handa M; Toyoda Y; Nishihira H; Tanaka Y; Sasaki Y; Ishida S; Higashino F; Fujinaga K
    Genes Chromosomes Cancer; 1996 Feb; 15(2):115-21. PubMed ID: 8834175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
    Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
    Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma.
    Kaneko Y; Kobayashi H; Handa M; Satake N; Maseki N
    Genes Chromosomes Cancer; 1997 Mar; 18(3):228-31. PubMed ID: 9071576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EWS-Oct-4 fusion gene encodes a transforming gene.
    Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
    Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma.
    Obata K; Hiraga H; Nojima T; Yoshida MC; Abe S
    Genes Chromosomes Cancer; 1999 May; 25(1):6-15. PubMed ID: 10221334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
    Bertolotti A; Bell B; Tora L
    Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
    Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
    Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
    Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
    Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 93.